Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study.

Mahdi H, Rose PG, El-Shaikh MA, Munkarah A, Isrow D, Singh S, Waggoner S, Ali-Fehmi R, Morris RT, Harding J, DeBenardo R.

Gynecol Oncol. 2015 Jan 7. pii: S0090-8258(14)01632-1. doi: 10.1016/j.ygyno.2014.12.034. [Epub ahead of print]

PMID:
25575483
[PubMed - as supplied by publisher]
2.

Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer.

Mahdi H, Munkarah AR, Ali-Fehmi R, Woessner J, Shah SN, Moslemi-Kebria M.

Arch Gynecol Obstet. 2014 Dec 31. [Epub ahead of print]

PMID:
25549769
[PubMed - as supplied by publisher]
3.

Vanishing endometrial cancer in hysterectomy specimens: a myth or a fact.

Ahmed QF, Gattoc L, Al-Wahab Z, Abdulfatah E, Ruterbusch JJ, Cote M, Bandyopadhyay S, Morris RT, Ali-Fehmi R.

Am J Surg Pathol. 2015 Feb;39(2):221-6. doi: 10.1097/PAS.0000000000000361.

PMID:
25517962
[PubMed - in process]
4.

Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: A multi-institution study.

Elshaikh MA, Al-Wahab Z, Mahdi H, Albuquerque K, Mahan M, Kehoe SM, Ali-Fehmi R, Rose PG, Munkarah AR.

Gynecol Oncol. 2014 Dec 12. pii: S0090-8258(14)01567-4. doi: 10.1016/j.ygyno.2014.12.012. [Epub ahead of print]

PMID:
25511158
[PubMed - as supplied by publisher]
5.

Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?

Winer I, Ahmed QF, Mert I, Bandyopadhyay S, Cote M, Munkarah AR, Hussein Y, Al-Wahab Z, Elshaikh MA, Alosh B, Schultz DS, Mahdi H, Nucci MR, Van de Vijver KK, Morris RT, Oliva E, Ali-Fehmi R.

Int J Gynecol Pathol. 2015 Jan;34(1):47-56. doi: 10.1097/PGP.0000000000000113.

PMID:
25473753
[PubMed - in process]
6.

Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.

Mitro SD, Ali-Fehmi R, Bandyopadhyay S, Alosh B, Albashiti B, Radisky DC, Frost MH, Degnim AC, Ruterbusch JJ, Cote ML.

Breast J. 2014 Nov-Dec;20(6):571-7. doi: 10.1111/tbj.12331. Epub 2014 Sep 8.

PMID:
25200244
[PubMed - in process]
Free PMC Article
7.

Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis.

Ahmad A, Sethi S, Chen W, Ali-Fehmi R, Mittal S, Sarkar FH.

Am J Transl Res. 2014 Jul 18;6(4):384-90. eCollection 2014.

PMID:
25075255
[PubMed]
Free PMC Article
8.

Dietary energy balance modulates ovarian cancer progression and metastasis.

Al-Wahab Z, Tebbe C, Chhina J, Dar SA, Morris RT, Ali-Fehmi R, Giri S, Munkarah AR, Rattan R.

Oncotarget. 2014 Aug 15;5(15):6063-75.

PMID:
25026276
[PubMed - in process]
Free PMC Article
9.

The influence of comorbid conditions on racial disparities in endometrial cancer survival.

Ruterbusch JJ, Ali-Fehmi R, Olson SH, Sealy-Jefferson S, Rybicki BA, Hensley-Alford S, Elshaikh MA, Gaba AR, Schultz D, Munkarah AR, Cote ML.

Am J Obstet Gynecol. 2014 Dec;211(6):627.e1-9. doi: 10.1016/j.ajog.2014.06.036. Epub 2014 Jun 19.

PMID:
24954655
[PubMed - indexed for MEDLINE]
10.

Risk factors for recurrence and prognosis of low-grade endometrial adenocarcinoma; vaginal versus other sites.

Moschiano EJ, Barbuto DA, Walsh C, Singh K, Euscher ED, Roma AA, Ali-Fehmi R, Frauenhoffer EE, Montiel DP, Kim I, Djordjevic B, Malpica A, Hong SR, Silva EG.

Int J Gynecol Pathol. 2014 May;33(3):268-73. doi: 10.1097/PGP.0b013e31829c6757.

PMID:
24681738
[PubMed - in process]
11.

Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?

Cote ML, Ruterbusch JJ, Ahmed Q, Bandyopadhyay S, Alosh B, Abdulfatah E, Seward S, Morris R, Ali-Fehmi R.

Gynecol Oncol. 2014 Apr;133(1):38-42. doi: 10.1016/j.ygyno.2014.01.013.

PMID:
24680590
[PubMed - indexed for MEDLINE]
12.

Racial disparities in uterine clear cell carcinoma: a multi-institution study.

Al-Wahab ZR, Kumar S, Mutch DG, Dowdy SC, Hensley SA, Wang Y, Mahdi H, Ali-Fehmi R, Morris RT, Elshaikh M, Munkarah AR.

Int J Gynecol Cancer. 2014 Mar;24(3):541-8. doi: 10.1097/IGC.0000000000000068.

PMID:
24552897
[PubMed - in process]
13.

Gynecologic cancers: molecular updates.

Ahmed Q, Alosh B, Bandyopadhyay S, Ali-Fehmi R.

Clin Lab Med. 2013 Dec;33(4):911-25. doi: 10.1016/j.cll.2013.09.001. Review.

PMID:
24267195
[PubMed - indexed for MEDLINE]
14.

Breast carcinoma: molecular profiling and updates.

Bandyopadhyay S, Ali-Fehmi R.

Clin Lab Med. 2013 Dec;33(4):891-909. doi: 10.1016/j.cll.2013.08.009. Review.

PMID:
24267194
[PubMed - indexed for MEDLINE]
15.

Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? A large multi-institutional analysis.

Ahmed Q, Hussein Y, Hayek K, Bandyopadhyay S, Semaan A, Abdul-Karim F, Al-Wahab Z, Munkarah AR, Elshaikh MA, Alosh B, Nucci MR, Van de Vijver KK, Morris RT, Oliva E, Ali-Fehmi R.

Gynecol Oncol. 2014 Feb;132(2):372-6. doi: 10.1016/j.ygyno.2013.11.011. Epub 2013 Nov 19.

PMID:
24262874
[PubMed - indexed for MEDLINE]
16.

Racial disparities in Human Papillomavirus (HPV) associated head and neck cancer.

Jiron J, Sethi S, Ali-Fehmi R, Franceschi S, Struijk L, van Doorn LJ, Quint W, Kato I.

Am J Otolaryngol. 2014 Mar-Apr;35(2):147-53. doi: 10.1016/j.amjoto.2013.09.004. Epub 2013 Sep 28.

PMID:
24209992
[PubMed - indexed for MEDLINE]
17.

Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma.

Matsuo K, Nishimura M, Komurov K, Shahzad MM, Ali-Fehmi R, Roh JW, Lu C, Cody DD, Ram PT, Loizos N, Coleman RL, Sood AK.

Gynecol Oncol. 2014 Jan;132(1):166-75. doi: 10.1016/j.ygyno.2013.10.027. Epub 2013 Oct 29.

PMID:
24183729
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study.

Diaz De Vivar A, Roma AA, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, Mikami Y, Hong SR, Arville B, Teramoto N, Ali-Fehmi R, Rutgers JK, Tabassum F, Barbuto D, Aguilera-Barrantes I, Shaye-Brown A, Daya D, Silva EG.

Int J Gynecol Pathol. 2013 Nov;32(6):592-601. doi: 10.1097/PGP.0b013e31829952c6.

PMID:
24071876
[PubMed - indexed for MEDLINE]
19.

The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.

Euscher E, Fox P, Bassett R, Al-Ghawi H, Ali-Fehmi R, Barbuto D, Djordjevic B, Frauenhoffer E, Kim I, Hong SR, Montiel D, Moschiano E, Roma A, Silva E, Malpica A.

Am J Surg Pathol. 2013 Nov;37(11):1728-36. doi: 10.1097/PAS.0b013e318299f2ab.

PMID:
24061515
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Tumour angiogenesis regulation by the miR-200 family.

Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, Bottsford-Miller J, Liu Y, Kim SB, Unruh A, Gonzalez-Villasana V, Huang L, Zand B, Moreno-Smith M, Mangala LS, Taylor M, Dalton HJ, Sehgal V, Wen Y, Kang Y, Baggerly KA, Lee JS, Ram PT, Ravoori MK, Kundra V, Zhang X, Ali-Fehmi R, Gonzalez-Angulo AM, Massion PP, Calin GA, Lopez-Berestein G, Zhang W, Sood AK.

Nat Commun. 2013;4:2427. doi: 10.1038/ncomms3427.

PMID:
24018975
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk